… of diabetic cardiomyopathy (17). The role of interstitial fibrosis in the pathogenesis of LV
hypertrophy in stable/early diabetic cardiomyopathy is … Cardiac magnetic resonance (CMR) T1 …

… The increasing prevalence of diabetic cardiomyopathy (DCM) is an important threat to health
worldwide. While left ventricular (LV) dysfunction in DCM is well recognized, the accurate …

… are unique, raising the prospect of diabetes-specific therapeutic intervention. Here, we …
the pathogenesis of diabetic cardiomyopathy and associated metabolic remodeling with an eye …

… We hypothesized that CRP overexpression might worsen diabetic cardiomyopathy
through … diabetic cardiomyopathy using human CRP-overexpressing transgenic mice (CRP-Tg). …

… beneficial in attenuating diabetic cardiomyopathy (DCM) but … α-MHCKO ) mice, and left
ventricular dimension, function, … , ADAM17 fl/fl diabetic and A17 α-MHCKO diabetic mice. Both …

… receptor type 2 (CCR2) (178), and macrophages derived from CCR 2+ monocytes are
required for adverse left ventricle remodeling (179). A recent study on mice demonstrated that the …

… cardiomyopathy. Thus, ACE2 provides a promising approach to the treatment of patients
with diabetic cardiomyopathy… Diabetic cardiomyopathy (DCM) is characterized by a variety of …

… is a good surrogate marker of diabetic cardiomyopathy and discussed the trials targeting
LVH as a manifestation of Stage B Cardiomyopathy, and potential mechanisms behind LVH …

… and the pathogenesis of cardiac remodeling that can lead to heart failure. We aimed to …
in diabetic cardiomyopathy (DCM). Streptozotocin (STZ) was used to induce a diabetic mouse …

… increased apoptosis, a slight increase in left ventricular size, and diastolic dysfunction and …
in left ventricular size, and a decrease in cardiac performance leading to heart failure. Recent …